Alnylam Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.72 | $120.37 M | -1.65 | 384 | $380.79 M |
 APLS
|
Apellis Pharmaceuticals, Inc. | $28.57 | $4.90 B | -11.77 | 702 | $396.59 M |
 BMRN
|
BioMarin Pharmaceutical Inc. | $66.00 | $15.32 B | 76.12 | 3401 | $2.42 B |
 BPMC
|
Blueprint Medicines Corporation | $91.88 | $6.47 B | -21.48 | 638 | $249.38 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.80 | $1.12 B | -5.11 | 174 | $0 |
 EXEL
|
Exelixis, Inc. | $34.29 | $6.37 B | 33.66 | 1310 | $1.83 B |
 HALO
|
Halozyme Therapeutics, Inc. | $58.45 | $6.47 B | 21.1 | 373 | $829.25 M |
 INCY
|
Incyte Corporation | $75.74 | $13.30 B | 17.93 | 2524 | $3.70 B |
|
ISEE
|
IVERIC bio, Inc. | $39.95 | $5.51 B | -22.44 | 163 | $0 |
 KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
 KRYS
|
Krystal Biotech, Inc. | $170.93 | $4.70 B | 75.42 | 229 | $50.70 M |
 MDGL
|
Madrigal Pharmaceuticals, Inc. | $331.16 | $5.21 B | -10.55 | 376 | $0 |
|
PRQR
|
ProQR Therapeutics N.V. | $3.63 | $151.08 M | -5.14 | 156 | $6.38 M |
 RARE
|
Ultragenyx Pharmaceutical Inc. | $51.02 | $3.44 B | -5.21 | 1276 | $434.25 M |
 RETA
|
Reata Pharmaceuticals, Inc. | $172.36 | $6.57 B | -66.29 | 321 | $2.22 M |
 SGEN
|
Seagen Inc. | $228.74 | $43.15 B | -57.19 | 3256 | $1.96 B |
 UTHR
|
United Therapeutics Corporation | $376.69 | $12.20 B | 13.02 | 1168 | $2.33 B |
 WVE
|
Wave Life Sciences Ltd. | $13.80 | $711.49 M | -11.39 | 266 | $113.31 M |